These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23391543)

  • 1. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 2. Xaliproden lessens oxaliplatin-mediated neuropathy.
    Susman E
    Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence from basic studies on mechanisms and treatment drugs for oxaliplatin-induced peripheral neuropathy].
    Egashira N; Kawashiri T; Oishi R
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):66-70. PubMed ID: 23391544
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 5. The pain with platinum: oxaliplatin and neuropathy.
    Kiernan MC
    Eur J Cancer; 2007 Dec; 43(18):2631-3. PubMed ID: 17977714
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and magnesium for oxaliplatin-induced neuropathy.
    Stansfield L
    Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
    Ushio S; Kawashiri T; Egashira N
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
    [No Abstract]   [Full Text] [Related]  

  • 9. [Roles of TRPA1 in acute peripheral neuropathy characteristically induced by oxaliplatin].
    Nakagawa T; Zhao M; Shirakawa H; Kaneko S
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):76-80. PubMed ID: 23391546
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
    Babiker HM; Green MR; Nelson MA; Elquza E
    Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral sensory neuropathy--fighting cold with cold.
    Castro M
    Lancet Oncol; 2008 May; 9(5):415-6. PubMed ID: 18452855
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer.
    Choi J; Kong K; Mozaffar T; Holcombe RF
    Anticancer Drugs; 2006 Jan; 17(1):103-5. PubMed ID: 16317297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.
    Sereno M; Gutiérrez-Gutiérrez G; Rubio JM; Apellániz-Ruiz M; Sánchez-Barroso L; Casado E; Falagan S; López-Gómez M; Merino M; Gómez-Raposo C; Rodriguez-Salas N; Tébar FZ; Rodríguez-Antona C
    BMC Cancer; 2017 Jan; 17(1):63. PubMed ID: 28103821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
    Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
    Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
    Argyriou AA; Antonacopoulou AG; Scopa CD; Kottorou A; Kominea A; Peroukides S; Kalofonos HP
    Oncology; 2009; 77(3-4):254-6. PubMed ID: 19738391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain?
    Stengel M; Baron R
    Pain; 2009 Aug; 144(3):225-226. PubMed ID: 19477073
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
    Atkins CD
    J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
    Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
    Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
    Taguchi K
    Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral Nerve Toxicity Caused by Oxaliplatin: Research Progress of Integrative Medicine].
    Zhang D; Yang YF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Aug; 35(8):1022-4. PubMed ID: 26485922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.